Profiles

Keywords
Last Name
Institution

Connection

Annabelle Volgman to Hemorrhage

This is a "connection" page, showing publications Annabelle Volgman has written about Hemorrhage.

 
Connection Strength
 
 
 
0.283
 
  1. Moseley A, Doukky R, Williams KA, Jaffer AK, Volgman AS. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation. J Womens Health (Larchmt). 2017 03; 26(3):214-221.
    View in: PubMed
    Score: 0.158
  2. Matetic A, Bharadwaj A, Mohamed MO, Chugh Y, Chugh S, Minissian M, Amin A, Van Spall H, Fischman DL, Savage M, Volgman AS, Mamas MA. Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction. Am J Cardiol. 2020 08 15; 129:10-18.
    View in: PubMed
    Score: 0.050
  3. Moseley AD, Collado FM, Volgman AS, Schaer GL, Snell RJ. Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article. Curr Atheroscler Rep. 2016 Jul; 18(7):45.
    View in: PubMed
    Score: 0.038
  4. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, Frison L, Halperin JL. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J. 2006 Aug; 27(16):1947-53.
    View in: PubMed
    Score: 0.019
  5. Wyse DG, Slee A, Epstein AE, Gersh BJ, Rocco T, Vidaillet H, Volgman A, Weiss R, Shemanski L, Greene HL. Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm. 2004 Nov; 1(5):531-7.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.